Roman Komorovsky

Dr. Roman Komorovsky

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in JACC
Verified
Journal Article
Closed access
ADAlessandro Desideri
Alessandro Desideri
LCLauro Cortigiani
Lauro Cortigiani
ACAlejandra Ines Christen
Alejandra Ines Christen
SCSebastian Coscarelli
Sebastian Coscarelli
Dario GregoriDario Gregori
Dario Gregori
JBJeroen J. Bax
Jeroen J. Bax

1 January 2023 in Current Cardiology Reviews
Verified
Journal Article
Closed access
PDF file
TLTetiana Lunova
Tetiana Lunova
RKRoman Komorovsky
Roman Komorovsky
IKIvan Klishch
Ivan Klishch
Background: We aimed to provide a comprehensive overview of existing gender differences in acute coronary syndrome (ACS), with respect to treatment delays, invasive management of ACS, and short and long-term mortality in patients with ACS. Methods: We defined 37 observational studies (OSs) and 21 randomized trials (RCTs) that best corresponded to our interests. OSs and RCTs were analyzed separately. Results: Women with ACS more often experienced delays in treatment compared to men (OR 1.43; 95% CI, 1.12-1.82) in RCTs. Female patients were less often treated invasively: RCTs (OR 0.87; 95% CI, 0.83-0.9), OSs: (OR 0.66; 95% CI, 0.63-0.68). Women had higher crude in-hospital mortality (OR 1.56; 95% CI, 1.53-1.59) and 30-day mortality (OR 1.71; 95% CI, 1.22-2.4) in OSs and (OR 2.74; 95% CI, 2.48-3.02) in RCTs. After adjustment for multiple covariates, gender difference was attenuated: in-hospital mortality (OR 1.19; 95% CI, 1.17-1.2), 30-day mortality (OR 1.18; 95% CI, 1.12-1.24) in OSs. Unadjusted long-term mortality in women was higher than in men (OR 1.41; 95% CI, 1.31-1.52) in RCTs and (OR 1.4; 95% CI, 1.3-1.5) in OSs. Conclusion: Women with ACS experience a delay in time to treatment more often than men. They are also less likely to be treated invasively. Females have shown worse crude short-and long-term all-cause mortality compared to males. However, after adjustment for multiple covariates, a less significant gender difference has been observed. Considering the difference between crude and adjusted mortality, we deem it reasonable to conduct further investigations on gender-related influence of particular risk factors on the outcomes of ACS.

1 January 2005 in Vascular Health and Risk Management
Verified
Journal Article
Closed access
RKRoman Komorovsky
Roman Komorovsky
ADAlessandro Desideri
Alessandro Desideri
Carotid disease is a common finding in patients with coronary artery disease (CAD) and its presence is associated with worse clinical outcomes. Intima-media thickness provides incremental value over traditional risk factors in predicting cardiovascular events; however, it does not predict the absence of CAD or its extent and severity. The presence of carotid plaques is associated with an increased risk of cardiovascular events in patients with CAD regardless of the treatment strategy (medical therapy alone or myocardial revascularization). Hence, we advocate the screening of patients with diagnosed CAD for carotid atherosclerosis. The prognostic impact of ultrasound characteristics of carotid plaques on cardiovascular outcomes of patients with CAD remains controversial.

1 January 2005 in The American Journal of Cardiology
Verified
Journal Article
Closed access
RKRoman Komorovsky
Roman Komorovsky
ADAlessandro Desideri
Alessandro Desideri
SCSebastian Coscarelli
Sebastian Coscarelli
LCLauro Cortigiani
Lauro Cortigiani
DTDiego Tonello
Diego Tonello
LCLeopoldo Celegon
Leopoldo Celegon

1 June 2004 in The American Journal of Cardiology
Verified
Journal Article
Open access
PDF file
RKRoman Komorovsky
Roman Komorovsky
ADAlessandro Desideri
Alessandro Desideri
SCSebastian Coscarelli
Sebastian Coscarelli
LCLauro Cortigiani
Lauro Cortigiani
LCLeopoldo Celegon
Leopoldo Celegon
The present prospective observational study was conducted in 323 consecutive patients with acute coronary syndrome, 101 (31%) of whom were diagnosed with carotid arterial narrowing by ultrasonography. At follow-up, patients with carotid disease had a greater incidence of cardiovascular events than did those with normal carotid arteries. Outcomes of patients with concomitant carotid disease who underwent cardiac revascularization were similar to those who received conservative treatment.

1 March 2026 in Journal of Pain Research
Verified
Journal Article
Open access
Fedir HladkykhFedir Hladkykh
Fedir Hladkykh
TLTetiana Liadova
Tetiana Liadova
MMMariia Matvieienko
Mariia Matvieienko
RKRoman Komorovsky
Roman Komorovsky
SSSvitlana Smiyan
Svitlana Smiyan
VSVolodymyr Student
Volodymyr Student
Central sensitization explains the mismatch between structural damage or inflammation and pain intensity in chronic musculoskeletal diseases. It defines the phenotype of fibromyalgia and contributes to persistent pain in osteoarthritis, rheumatoid arthritis, and psoriatic arthritis. To characterize the role of central sensitization in nociplastic pain in fibromyalgia, osteoarthritis, rheumatoid arthritis, and psoriatic arthritis. A structured search of PubMed, Scopus, Web of Science, and Google Scholar (1990–2025) identified open-access, evidence-based publications addressing pain pathophysiology, diagnosis, and treatment in these conditions. Central sensitization manifests as hyperalgesia, allodynia, expanded receptive fields, and impaired endogenous pain inhibition. It predominates in fibromyalgia and contributes to persistent pain in osteoarthritis and rheumatoid arthritis that may not correlate with inflammation or structural damage. Screening tools such as the Widespread Pain Index and Symptom Severity Scale, together with quantitative sensory testing and algometry, help identify nociplastic pain features. Neuroimmune mechanisms, including microglial activation and imbalance between excitatory and inhibitory neurotransmission, may contribute to the mismatch between pain intensity and clinical findings. Chronic pain reflects inflammatory, mechanical, and nociplastic mechanisms in rheumatoid arthritis, osteoarthritis, and fibromyalgia, respectively. Recognition of central sensitization improves assessment and supports mechanism-based management.